Therapeutic agents 713

Details for Australian Patent Application No. 2010243341 (hide)

Owner AstraZeneca AB

Inventors Johansson, Lars Anders Mikael; Judkins, Robert Andrew; Li, Lanna; Lofberg, Bjorn Christian Ingvar; Persson, Joachim

Agent Davies Collison Cave

Pub. Number AU-A-2010243341

PCT Pub. Number WO2010/125390

Priority 61/174,630 01.05.09 US

Filing date 29 April 2010

Wipo publication date 4 November 2010

International Classifications

C07D 491/10 (2006.01) Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

A61K 31/4245 (2006.01) - Oxadiazoles

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/125390 Priority application(s): WO2010/125390

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010243345-Improvements in or relating to scanning ophthalmoscopes

2010243340-UV liquid steriliser